Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lynn Smiley"'
Autor:
Ashley M, Delgado, Thomas, Prihoda, Carol, Nguyen, Beatriz, Hicks, Lynn, Smiley, Melanie, Taverna
Publikováno v:
Journal of dental hygiene : JDH. 90(4)
As recently as the 1990s long-term care facilities (LTCFs) were the main housing option for semi- or fully-dependent elders. Today, 90% of those 65 and older want to "age in place." The growth of the elderly population that want to "age in place" wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6060ba66896a95f0220e368aa7ae5255
https://pubmed.ncbi.nlm.nih.gov/27551145
https://pubmed.ncbi.nlm.nih.gov/27551145
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 21:600-607
Among the most promising of the new therapies being developed for the treatment of Cystic Fibrosis (CF) are those targeted at increasing mucosal hydration on the surface of the airways. One of these therapies, P2Y(2) receptor agonists, bypasses the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0333300dbd5b3006a2254ca3ffed1169
https://doi.org/10.1016/j.pupt.2007.12.003
https://doi.org/10.1016/j.pupt.2007.12.003
Publikováno v:
Reviews in Medical Virology. 14:321-337
The end of the twentieth century saw dramatic improvements in the prognosis of HIV infection brought about by the introduction of new agents (the protease inhibitors and the non-nucleoside reverse transcriptase inhibitors) and their use in highly act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b46afe37fb42184f155b6bd28d3a86
https://doi.org/10.1002/rmv.440
https://doi.org/10.1002/rmv.440
Autor:
Lynn Smiley, David M. Cocchetto
Publikováno v:
Drug Information Journal. 33:357-372
The pharmaceutical industry and the Food and Drug Administration (FDA) have responded for over a decade to the considerable challenges of drug development and registration, as introduced by the HIV epidemic. FDA took a variety of regulatory steps ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f420456a7c63794331877af7867d933
https://doi.org/10.1177/009286159903300206
https://doi.org/10.1177/009286159903300206
Autor:
Nancy Herje, A. Schaberg, Todd A. Durham, Clement L. Ren, Carole M. Evans, Brian J. Burke, Tomas Navratil, Fred L. Johnson, Felix Ratjen, Richard B. Moss, Lynn Smiley, Frank J. Accurso
Publikováno v:
D94. CYSTIC FIBROSIS: FROM CLINIC TO LAB AND BACK.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07094fadb7599e65fd73f06beced0081
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6581
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6581
Autor:
Todd A. Durham, Nancy Herje, Amy E. Schaberg, George Z. Retsch-Bogart, Lynn Smiley, Carolyn Deans, Tomas Navratil, Frank J. Accurso
Publikováno v:
A53. CYSTIC FIBROSIS: CLINICAL PEDIATRIC STUDIES.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::970874823b4a95a5269284c84a543b72
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1842
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1842
Autor:
Kent J. Weinhold, Gilbert C. White, Thomas J. Matthews, Paul Becherer, M. Lynn Smiley, Campbell W. McMillan
Publikováno v:
American Journal of Hematology. 34:204-209
A retrospective study of 153 hemophiliacs infected with human immunodeficiency virus-1 (HIV-1) was performed to determine the clinical and immunological consequences of HIV-1 infection and the markers and cofactors associated with these changes. Near
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d67ffeecfe3aaa3d8bad1db550ae291
https://doi.org/10.1002/ajh.2830340310
https://doi.org/10.1002/ajh.2830340310
Autor:
Tosca Kinchelow, Denise Guimaraes, Peter J. Piliero, Miklos Salgo, David A. Cooper, Fiona Hughes, Calvin Cohen, Emily Labriola-Tompkins, Hans-Jiirgen Stellbrink, Silvia Bader-Weder, Lynn Smiley, Laurence Bourdeau, Daniel R. Kuritzkes, Benoit Trottier, Anne Bertasso, Julio S. G. Montaner, Joep M. A. Lange, Adriano Lazzarin, Sharon Walmsley, Christine Katlama, Jacques Reynes, Mary O'Hearn, Jacob Lalezari, Keith Henry, Jean-François Delfraissy, Belinda Atkins, Keikanus Arasteh, Bonaventura Clotet, Anna Shikhman, Mark T. Nelson, Jain Chung, Ralph DeMasi, Claude Drobnes, Christopher Natale, Joseph J. Eron
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 40(4), 413-421. Lippincott Williams and Wilkins
Background: Antiretroviral tolerability is a critical factor contributing to treatment outcome. The T-20 Versus Optimized Background Regimen Only (TORO) studies assessed the safety and efficacy of enfuvirtide in treatment-experienced HIV-1-infected p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1e08c182cf8ae96415ce5527f8d3e9
https://pubmed.ncbi.nlm.nih.gov/16280695
https://pubmed.ncbi.nlm.nih.gov/16280695
Autor:
Joep M. A. Lange, Jean François Delfraissy, Adriano Lazzarin, Lucille Donatacci, Keith Henry, Neil Buss, Martin Wilkinson, Bonaventura Clotet, David A. Cooper, Mary O'Hearn, Jacob Lalezari, Mark T. Nelson, Julio S. G. Montaner, Jain Chung, Jacques Reynes, Hans Jürgen Stellbrink, Daniel R. Kuritzkes, Miklos Salgo, Adeline Valentine, Peter J. Piliero, Sharon Walmsley, Calvin Cohen, Christine Katlama, Cynthia Wat, Lynn Smiley, Joseph J. Eron, Denise Guimaraes, Benoit Trottier, Keikawus Arastéh, Ralph DeMasi
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 40(4), 404-412. Lippincott Williams and Wilkins
BACKGROUND The T-20 Versus Optimized Background Regimen Only (TORO) 1 and TORO 2 clinical trials are open-label, controlled, parallel-group, phase 3 studies comparing enfuvirtide plus an optimized background (OB) of antiretrovirals (n = 661) with OB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e00bcc88e61ef05ead623d3f1fa1873
https://pure.amc.nl/en/publications/durable-efficacy-of-enfuvirtide-over-48-weeks-in-heavily-treatmentexperienced-hiv1infected-patients-in-the-t20-versus-optimized-background-regimen-only-1-and-2-clinical-trials(4eb2f353-46e3-4061-84af-7df5191c9cad).html
https://pure.amc.nl/en/publications/durable-efficacy-of-enfuvirtide-over-48-weeks-in-heavily-treatmentexperienced-hiv1infected-patients-in-the-t20-versus-optimized-background-regimen-only-1-and-2-clinical-trials(4eb2f353-46e3-4061-84af-7df5191c9cad).html
Publikováno v:
Cases in Medical Microbiology and Infectious Diseases, Third Edition ISBN: 9781555816353
Cases in Medical Microbiology and Infectious Diseases, Third Edition
Cases in Medical Microbiology and Infectious Diseases, Third Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ddafb97abe58a1360af6e8acda99fb4
https://doi.org/10.1128/9781555816353.ch4
https://doi.org/10.1128/9781555816353.ch4